3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
4
Primary Myelofibrosis
3
Polycythemia Vera
2
Myelodysplastic Syndromes
2
Lymphoma, T-Cell
2
Leukemia
2
Graft vs Host Disease
2
Thrombocythemia, Essential
1
Thalassemia
1
Preleukemia
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, B-Cell
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Glioma
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Bronchiolitis Obliterans Syndrome
1
Bone Marrow Diseases
1
Interventions
Vincristine
5
merphos
4
Methotrexate
4
Dexamethasone
4
Cytarabine
4
Cyclophosphamide
4
pegaspargase
3
dexamethasone acetate
3
dexamethasone 21-phosphate
3
blinatumomab
3
azathiopurine
3
auricularum
3
Mercaptopurine
3
Leucovorin
3
Doxorubicin
3
Calcium Dobesilate
3
prednylidene
2
deltacortene
2
asparaginase erwinia chrysanthemi recombinant
2
Thioguanine
2
Spinal Puncture
2
Specimen Handling
2
Prednisone
2
N,N-dicyclohexyl-isoborneol-10-sulfonamide
2
Inotuzumab Ozogamicin
2
Asparaginase
2
venetoclax
1
ofatumumab
1
calaspargase pegol
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
×
ruxolitinib
×
30 days
×
Clear all
No trials found.